BRIEF—Bristol Myers open major biologics facility in Dublin

Bristol Myers Squibb has opened its Cruiserath Biologics site in Dublin, Ireland, a 125-acre facility with approval from US and EU regulators, costing $1 billion to develop.

The site was designed as a flexible, multi-product manufacturing operation with capacity to meet growing demand for existing biologics products and future launches.

Global manufacturing chief Karin Shanahan said the site would “play a crucial role in our company’s success moving forward.”

She added: “Coupled with the breadth of knowledge and expertise of our employees, this multi-product site will allow us to further enhance our operations as we strive to get more medicines to more patients faster.”